Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817217-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 30, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
23,205
Total Value
$66,524.07
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 41,342 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 44,200 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Exercise/Conversion | 3,572 | $0.00 | $0.00 | 47,772 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 2,845 | $23.38 | $66,524.07 | 44,927 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jul 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 11,250 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jul 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 20,009 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jul 30, 2026 | Exercise/Conversion | 3,572 | $0.00 | $0.00 | 39,303 | Direct | โ | View Details |